HPV, hypoxia and radiation response in head and neck cancer. (Q54264285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

HPV, hypoxia and radiation response in head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Eva-Leonne Göttgens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Christian Ostheimer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Jan Bussink

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

14 March 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Radiology

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

20180047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

18 March 2020

cites work

1 reference

12 December 2020

2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

1 reference

12 December 2020

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

12 December 2020

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

12 December 2020

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

12 December 2020

Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study

1 reference

12 December 2020

Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation

1 reference

12 December 2020

Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma

1 reference

12 December 2020

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy

1 reference

12 December 2020

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

1 reference

12 December 2020

Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation

1 reference

12 December 2020

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

12 December 2020

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

1 reference

12 December 2020

The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

1 reference

12 December 2020

Tumor-specific gene delivery using genetically engineered bacteria

1 reference

12 December 2020

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

12 December 2020

Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.

1 reference

12 December 2020

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

12 December 2020

Clinical implications of human papillomavirus in head and neck cancers

1 reference

12 December 2020

Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours

1 reference

12 December 2020

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

1 reference

12 December 2020

Bacterial targeted tumour therapy-dawn of a new era.

1 reference

12 December 2020

Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

1 reference

12 December 2020

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

1 reference

12 December 2020

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

1 reference

12 December 2020

Insights into the role and function of L2, the minor capsid protein of papillomaviruses

1 reference

12 December 2020

Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors

1 reference

12 December 2020

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

1 reference

12 December 2020

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer

1 reference

12 December 2020

Tumour targeting with systemically administered bacteria.

1 reference

12 December 2020

PET-CT for response assessment and treatment adaptation in head and neck cancer

1 reference

12 December 2020

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

1 reference

12 December 2020

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

12 December 2020

Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway

1 reference

12 December 2020

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

1 reference

12 December 2020

Targeting Hypoxic Cells through the DNA Damage Response

1 reference

12 December 2020

PET-CT for radiotherapy treatment planning and response monitoring in solid tumors

1 reference

12 December 2020

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial

1 reference

12 December 2020

Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis

1 reference

12 December 2020

The mutational landscape of head and neck squamous cell carcinoma

1 reference

12 December 2020

Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer

1 reference

12 December 2020

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.

1 reference

12 December 2020

Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy

1 reference

12 December 2020

Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial

1 reference

12 December 2020

Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.

1 reference

12 December 2020

Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients

1 reference

12 December 2020

The prognostic significance of hypoxia inducing factor 1-α in oropharyngeal cancer in relation to human papillomavirus status.

1 reference

12 December 2020

Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.

1 reference

12 December 2020

HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity

1 reference

12 December 2020

CK2 phosphorylation inactivates DNA binding by the papillomavirus E1 and E2 proteins.

1 reference

12 December 2020

Enhanced radiation sensitivity in HPV-positive head and neck cancer

1 reference

12 December 2020

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer

1 reference

12 December 2020

Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia

1 reference

12 December 2020

Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma

1 reference

12 December 2020

Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells

1 reference

12 December 2020

Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review).

1 reference

12 December 2020

Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials

1 reference

12 December 2020

Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer

1 reference

12 December 2020

The meaning, measurement and modification of hypoxia in the laboratory and the clinic.

1 reference

12 December 2020

Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas

1 reference

12 December 2020

Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis

1 reference

12 December 2020

Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage

1 reference

12 December 2020

Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models

1 reference

12 December 2020

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology G

1 reference

12 December 2020

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

1 reference

12 December 2020

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.

1 reference

12 December 2020

High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma

1 reference

12 December 2020

TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging.

1 reference

12 December 2020

IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma

1 reference

12 December 2020

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

1 reference

12 December 2020

Targeting hypoxia at the forefront of anticancer immune responses

1 reference

12 December 2020

HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx

1 reference

12 December 2020

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).

1 reference

12 December 2020

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs.

1 reference

12 December 2020

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

1 reference

12 December 2020

DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma

1 reference

12 December 2020

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma

1 reference

12 December 2020

Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives

1 reference

12 December 2020

Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment

1 reference

12 December 2020

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma

1 reference

12 December 2020

Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs

1 reference

12 December 2020

Hypoxia Responsive Drug Delivery Systems in Tumor Therapy

1 reference

12 December 2020

Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.

1 reference

12 December 2020

Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers

1 reference

12 December 2020

Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy

1 reference

12 December 2020

TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects

1 reference

12 December 2020

Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.

1 reference

12 December 2020

Human papillomavirus in oropharyngeal cancer: The changing face of a disease

1 reference

12 December 2020

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial

1 reference

12 December 2020

Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis

1 reference

12 December 2020

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.

1 reference

12 December 2020

Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases

1 reference

12 December 2020

Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity

1 reference

12 December 2020

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy

1 reference

12 December 2020

Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy

1 reference

12 December 2020

Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts

1 reference

12 December 2020

Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.

1 reference

12 December 2020

Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.

1 reference

12 December 2020

Lactate stimulates CA IX expression in normoxic cancer cells.

1 reference

12 December 2020

Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.

1 reference

12 December 2020

Identifiers

DOI

10.1259/BJR.20180047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

29493265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29493265%20AND%20SRC:MED&resulttype=core&format=json